“gene-editing” Archives

in
Entry Author Date Location
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs 03/06/19 Boston
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
Plant-Breeding Biotech Cibus Delays IPO, Citing Market Conditions 02/14/19 San Diego
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit 02/07/19 San Francisco
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More 01/25/19 National
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial 01/22/19 Boston
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More 01/04/19 National
From Alnylam to Zayner: Xconomy’s Top Innovation Stories of 2018 12/27/18 National
Gilbert Foundation to Pursue Gene Therapy for Neurofibromatosis 12/20/18 Detroit Ann Arbor
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
“JK Told Me He Was Planning This”: A CRISPR Baby Q&A with Matt Porteus 12/04/18 National
Bio Roundup: CRISPR Babies, Blood Diseases, Big Cancer Nod & More 11/30/18 National
Agbio Startup Cibus Files for an IPO to Support Gene-Editing R&D 11/19/18 San Diego
Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More 11/02/18 National
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Allogene’s IPO Raises $288M for Tests of “Off-the-Shelf” Cell Therapy 10/11/18 San Francisco
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test 10/10/18 Boston
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
U.S. Court Affirms Broad’s CRISPR Patent; No Word of Berkeley Appeal 09/10/18 Boston
Sangamo 1st to Show Human Gene-Editing Results. Investors Say ‘Meh.’ 09/05/18 San Francisco
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More 08/31/18 National
Inari Agriculture Harvests $40M to Ramp Up Gene Editing R&D 08/09/18 Boston
Announcing XCON 2018: A Conference on Technology and Transformation 07/24/18 Boston
Sangamo Bags TxCell, and a Next-Gen Cell Therapy Tech, for $84M 07/23/18 San Francisco
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Inari Agriculture Sprouts with Plans to Gene Edit “Personalized Seeds” 07/18/18 Boston
New Study Shows CRISPR Can Delete Big Chunks of DNA 07/16/18 National
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Page 2 of 6 « previous page · next page »